Collaborative study to evaluate the candidate 3rd WHO international standard for hepatitis B surface antigen
WHO Expert Committee on Biological Standardization & World Health Organization. (2014). Collaborative study to evaluate the candidate 3rd WHO international standard for hepatitis B surface antigen. World Health Organization. http://www.who.int/iris/handle/10665/137473
Gov't Doc #WHO/BS/2014.2241
MetadataShow full item record
Showing items related by title and MeSH subject.
A collaborative study of the proposed international reference preparation for hepatitis B vaccine containing plasma-derived hepatitis B surface antigen (HBsAg / by Morag Ferguson, Valerie Seagroat and Geoffrey C. Schild Ferguson, Morag; Seagroatt, Valerie; Schild, Geoffrey Christopher; World Health Organization. Biologicals Unit (WHO/BS/86.1525, Rev.1. Unpublished, 1986)
Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt Wasfi, O.A.S.; Sadek, N.A. (2011)Hepatitis B and C virus infections are common serious complications of blood transfusion. Over a 6-month period in 2007/08 all samples from a blood bank in Alexandria, Egypt [n=3420] were tested for hepatitis B surface antigen [HBsAg] and anti-hepatitis C virus [HCV] antibodies. A total of 119 donors [3.5%] were positive for anti-HCV and 47 [1.4%] for HBsAg. The mean age of HCV - positive donors was significantly higher than HBV-positive donors: 35.7 [SD 83] versus 29.9 [SD 7.4] years, HCV and HBV prevalence was highest among males [93.3% and ...
Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran Ghavanini, A.A.; Sabri, M.R. (2000)We determined the prevalence rate of hepatitis B surface antigen [HBsAg] and anti-hepatitis C virus antibodies [anti-HCV] among 7897 healthy voluntary blood donors in Shiraz, Islamic Republic of Iran. Sera were examined for HBsAg and anti-HCV antibodies using a second-generation enzyme-linked immunosorbent assay. Positive sera for HBsAg were found in 85 [1.07%] of the individuals and anti-HCV antibodies were found in 47 [0.59%]. We compared our results with those of other studies and conclude that the prevalence rate of HBsAg in our area has ...